Capital World Investors - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 829 filers reported holding NOVARTIS A G in Q1 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.

Quarter-by-quarter ownership
Capital World Investors ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,166,175
+6.1%
30,941
+3.0%
0.00%0.0%
Q2 2023$2,983,989
+9.5%
30,032
+0.9%
0.00%0.0%
Q1 2023$2,724,879
+1.7%
29,754
+1.7%
0.00%0.0%
Q4 2022$2,680,483
-42.1%
29,263
-51.6%
0.00%0.0%
Q3 2022$4,630,000
-94.2%
60,463
-93.6%
0.00%
-94.1%
Q2 2022$80,229,000
+76.8%
948,953
+83.5%
0.02%
+112.5%
Q1 2022$45,386,000
-3.9%
517,113
-4.2%
0.01%
+14.3%
Q4 2021$47,214,000
+7.4%
539,778
+0.6%
0.01%
-12.5%
Q3 2021$43,947,000
-9.3%
536,486
+1.1%
0.01%0.0%
Q2 2021$48,455,000
+17.4%
530,679
+10.0%
0.01%0.0%
Q1 2021$41,290,000
-7.9%
482,288
+1.5%
0.01%
-11.1%
Q4 2020$44,850,000
+45.6%
474,983
+34.1%
0.01%
+28.6%
Q3 2020$30,810,000
-61.0%
354,281
-60.8%
0.01%
-63.2%
Q2 2020$78,932,000
+184.2%
903,739
+168.3%
0.02%
+137.5%
Q1 2020$27,770,000
+46.8%
336,883
+68.7%
0.01%
+100.0%
Q4 2019$18,913,000
+9.8%
199,745
+0.8%
0.00%0.0%
Q3 2019$17,223,000
-2.4%
198,165
+2.5%
0.00%0.0%
Q2 2019$17,653,000
-4.9%
193,331
+0.2%
0.00%0.0%
Q1 2019$18,556,000
-50.9%
193,015
-56.1%
0.00%
-60.0%
Q4 2018$37,758,000
-0.4%
440,0150.0%0.01%
+11.1%
Q3 2018$37,912,000
+14.1%
440,015
+0.0%
0.01%
+28.6%
Q2 2018$33,239,000
-6.6%
440,0140.0%0.01%
-12.5%
Q1 2018$35,575,000
+3557400.0%
440,014
+3666683.3%
0.01%
Q4 2017$1,0000.0%12
+20.0%
0.00%
Q3 2017$1,00010
+150.0%
0.00%
Q2 2017$0
-100.0%
4
-100.0%
0.00%
-100.0%
Q4 2016$104,497,000
-31.6%
1,434,611
-25.9%
0.03%
-35.0%
Q3 2016$152,781,000
+1.0%
1,934,918
+5.5%
0.04%
-2.4%
Q2 2016$151,323,000
+13.9%
1,834,0000.0%0.04%
+10.8%
Q1 2016$132,855,000
+65.3%
1,834,000
+96.4%
0.04%
+68.2%
Q4 2015$80,361,000
-6.4%
934,0000.0%0.02%
-12.0%
Q3 2015$85,853,000
-6.5%
934,0000.0%0.02%0.0%
Q2 2015$91,850,000
-0.3%
934,0000.0%0.02%0.0%
Q1 2015$92,102,000
+6.4%
934,0000.0%0.02%
+8.7%
Q4 2014$86,544,000
-1.6%
934,0000.0%0.02%
-8.0%
Q3 2014$87,917,000
+4.0%
934,0000.0%0.02%
+8.7%
Q2 2014$84,555,000
+6.5%
934,0000.0%0.02%0.0%
Q1 2014$79,409,000
+5.8%
934,0000.0%0.02%
+9.5%
Q4 2013$75,075,000
+4.8%
934,0000.0%0.02%
-4.5%
Q3 2013$71,647,000
+35.8%
934,000
+25.2%
0.02%
+29.4%
Q2 2013$52,750,000746,0000.02%
Other shareholders
NOVARTIS A G shareholders Q1 2014
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders